Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes.
about
Amelioration of type 1 diabetes following treatment of non-obese diabetic mice with INGAP and lisofylline.12-Lipoxygenase Products Reduce Insulin Secretion and {beta}-Cell Viability in Human IsletsAn intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells.12/15-lipoxygenase products induce inflammation and impair insulin signaling in 3T3-L1 adipocytes.Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.Prevention of autoimmune diabetes and induction of β-cell proliferation in NOD mice by hyperbaric oxygen therapy.An update on the use of NOD mice to study autoimmune (Type 1) diabetes.Enhancing pancreatic Beta-cell regeneration in vivo with pioglitazone and alogliptin.Testing agents for prevention or reversal of type 1 diabetes in rodents.Activation of the GLP-1 receptor signalling pathway: a relevant strategy to repair a deficient beta-cell massHepatitis B Virus Stimulated Fibronectin Facilitates Viral Maintenance and Replication through Two Distinct Mechanisms.Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD miceExendin-4 modulates diabetes onset in nonobese diabetic miceEpithelial restitution and wound healing in inflammatory bowel disease.Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice.Extrinsic factors involved in the differentiation of stem cells into insulin-producing cells: an overview.Exenatide: a new promising antidiabetic agentInsulin - producing cells derived from stem cells: recent progress and future directions.Type 1 Interferons Potentiate Human CD8+ T-Cell Cytotoxicity Through a STAT4- and Granzyme B-Dependent Pathway.
P2860
Q30370459-9B7C56AA-074F-447A-AEA1-C8C5295EB00EQ30433351-2067FD3D-74BF-4E5A-BEF9-1DBDD18C4BB3Q30435561-0DE7C34B-7E20-4438-8008-3C2E3E47E774Q30435822-93B5A6B0-0518-4737-BA32-DA9A05894195Q30437086-7A416715-4066-480C-BEB2-3E7C5D5BB247Q34273412-1920BD30-9371-4DF1-8938-5A03AAB018DFQ34508281-853ABCDC-DB25-4750-BB79-0218C8A910C9Q34770205-86B8C780-066D-4B2B-93D7-8FE441926173Q34983677-E08E3909-4A7B-4D54-BEF6-A105CC40E7C2Q35055522-491E1F9A-86C8-4960-B515-B7A9BCFB24C4Q35972785-F141002A-D398-4F6B-954D-0D8E12E7D220Q36228938-D10229A0-D0D3-47FB-BBB7-C2DD52EA73C2Q36509803-758EBF71-8612-4D38-AD92-EF39A4444050Q37058859-AF6CD396-7C4D-4C5A-B555-7D8D13297A79Q37360439-5220385A-6EEE-45EE-9825-3B74F2CE961FQ37900149-059B12C7-9297-4F8A-9F26-1AC6DAEE889AQ40964981-599F9698-9960-4B64-90A7-76EC760740C6Q45899851-377D6171-1C95-4809-A880-DB14F3E85951Q47709251-AFF5401B-AE4F-4B69-AADB-4D581F320B88
P2860
Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes.
@ast
Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes.
@en
type
label
Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes.
@ast
Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes.
@en
prefLabel
Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes.
@ast
Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes.
@en
P2093
P1476
Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes.
@en
P2093
James C Garmey
Jeffrey D Carter
Jerry L Nadler
Sarah D Kimble
Zandong Yang
P304
P356
10.1016/J.BBRC.2006.03.204
P407
P577
2006-04-05T00:00:00Z